Euflexxa Alternatives Compared
| Euflexxa (sodium hyaluronate) | Meloxicam | Celebrex (celecoxib) |
|
|---|
| Euflexxa (sodium hyaluronate) | Meloxicam | Celebrex (celecoxib) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Osteoarthritis. Euflexxa may also be used for purposes not listed in this medication guide. |
Prescription only
Meloxicam is effective for the short-term relief of pain and inflammation associated with arthritis; however, like other NSAIDs, it has the potential to adversely affect the stomach or heart and... View more |
Prescription only
Celebrex is a COX-2-specific NSAID that has a lower propensity for gastrointestinal side effects than many other NSAIDs; however, it still may increase the risk of serious cardiovascular thrombotic... View more |
Related suggestions Osteoarthritis
|
|||||||||||||||
| More about Euflexxa (sodium hyaluronate) | More about Meloxicam | More about Celebrex (celecoxib) | ||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||
|
Euflexxa has an average rating of 6.2 out of 10 from a total of 264 ratings on Drugs.com. 55% of reviewers reported a positive effect, while 35% reported a negative effect. |
Meloxicam has an average rating of 6.3 out of 10 from a total of 602 ratings on Drugs.com. 54% of reviewers reported a positive effect, while 33% reported a negative effect. |
Celebrex has an average rating of 7.0 out of 10 from a total of 226 ratings on Drugs.com. 64% of reviewers reported a positive effect, while 23% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||
View all Euflexxa side effects |
View all Meloxicam side effects |
View all Celebrex side effects |
||||||||||||||||
| Drug Class | ||||||||||||||||||
| Generic Availability | ||||||||||||||||||
|
N/A |
Lower cost generic |
|||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Meloxicam prices |
View all Celebrex prices |
||||||||||||||||
| Dosage Forms | ||||||||||||||||||
|
|
|
||||||||||||||||
| Brand Names | ||||||||||||||||||
| Other sodium hyaluronate brands include: Durolane, Gelsyn-3, Hyalgan, Supartz, Supartz FX | Qamzova, Xifyrm | Other celecoxib brands include: Elyxyb | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||
|
N/A |
20 hours |
11 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | ||||||||||||||||||
|
Category N
Not classified
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
Prior To 30 Weeks Gestation
Category D
Positive evidence of risk
Starting At 30 Weeks Gestation See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
Prior To 30 Weeks Gestation
Category D
Positive evidence of risk
Starting At 30 Weeks Gestation See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | ||||||||||||||||||
|
A total of 2 drugs are known to interact with Euflexxa:
|
A total of 473 drugs are known to interact with Meloxicam:
|
A total of 459 drugs are known to interact with Celebrex:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | ||||||||||||||||||
|
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||
| First Approval Date | ||||||||||||||||||
|
N/A |
April 13, 2000 |
December 31, 1998 |
||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| More Information | ||||||||||||||||||
| Patient Resources | ||||||||||||||||||
| Professional Resources | ||||||||||||||||||
|
N/A |
||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.